symphony_x
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| symphony_x [2024/10/09 23:37] – created mbates | symphony_x [2026/08/25 16:16] (current) – [About] zjnett | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== | + | ====== |
| ^ | ^ | ||
| - | | | | + | | {{symphonyX.jpg? |
| | **Tool Type: | | **Tool Type: | ||
| + | | **Manufacturer: | ||
| | **Location: | | **Location: | ||
| - | | **Supervisor** | **Tool Lead** | + | | **Principal Scientist** | **Training and Operations |
| - | | | + | | |
| - | | | + | | |
| - | | **Description: | ||
| - | | **Manufacturer: | ||
| ---- | ---- | ||
| Line 21: | Line 20: | ||
| The Symphony X (Gyros Protein Technologies) is a flexible, automated synthesizer that enables the preparation of novel peptides, peptoids, and other solid-phase synthesis sequence specific materials. It provides a viable route to non-commercial products, branched or cyclic materials, and a low-cost solution for non-natural amino acid-based peptides. The system also includes the ability to perform in-situ pre-activation, | The Symphony X (Gyros Protein Technologies) is a flexible, automated synthesizer that enables the preparation of novel peptides, peptoids, and other solid-phase synthesis sequence specific materials. It provides a viable route to non-commercial products, branched or cyclic materials, and a low-cost solution for non-natural amino acid-based peptides. The system also includes the ability to perform in-situ pre-activation, | ||
| - | Multi-user accessibility is facilitated via 24 fully independent reaction stations, enabling different sequences, scales, and protocols | + | Multi-user accessibility is facilitated via 12 fully independent reaction stations, enabling different sequences, scales, and protocols |
| ---- | ---- | ||
| - | ===== Detailed Specifications ===== | ||
| - | Coming soon. | ||
| - | |||
| - | ---- | ||
| ===== Safety Concerns ===== | ===== Safety Concerns ===== | ||
| - | Coming soon. | + | • Many peptide coupling agents (e.g., DIC, EDC, HBTU, HCTU and HATU) are known skin and respiratory sensitizers. Allergy symptoms, including dermatitis, hives, rhinitis (e.g., nasal congestion, |
| + | runny nose, sneezing, and itching), asthma, and potentially deadly anaphylaxis, | ||
| + | result of handling coupling agents. | ||
| + | • DMF and NMP, commonly used solvents, are toxic and can be readily absorbed through the skin, affecting the liver. Always wear proper PPE, including gloves, a lab coat, and, when pouring large volumes, a face shield and booties. | ||
| + | |||
| + | • To minimize exposure, perform all operations in a fume hood or ventilated cabinet, including opening reagent bottles, weighing, and transferring reagents. Dispose of contaminated materials in the labeled waste containers, and rinse glassware and tools in the fume hood into designated waste containers. | ||
| ---- | ---- | ||
| - | ===== Operating Procedures | + | ===== Reference Documentation |
| - | Coming soon. | + | {{ : |
| - | ===== Reference Documentation ===== | + | {{ : |
| + | |||
| + | {{ : | ||
| + | |||
| + | {{ : | ||
| + | |||
| + | [[https:// | ||
| - | Coming soon. | ||
| ----- | ----- | ||
symphony_x.1728517045.txt.gz · Last modified: by mbates
